EP1003581A1 — An injection syringe
Assigned to Novo Nordisk AS · Expires 2000-05-31 · 26y expired
What this patent protects
In an injection syringe comprising a housing (1), a piston rod (6) with a not circular cross section and an outer thread (7), a piston rod drive comprising a piston rod guide (85) mating the cross section of the piston rod (6) and a nut (4) which is not axially displaceable and m…
USPTO Abstract
In an injection syringe comprising a housing (1), a piston rod (6) with a not circular cross section and an outer thread (7), a piston rod drive comprising a piston rod guide (85) mating the cross section of the piston rod (6) and a nut (4) which is not axially displaceable and mates the thread (7) of the piston rod (6) to form a self locking thread connection, and a dose setting mechanism comprising a not self locking thread connection along which an injection button by rotation of a dose setting element (81) is screwed out to project from the housing (1) and which thread connection by axial returning of the injection button (88) transforms this axial movement into a rotation of one of the piston drive elements (85) relative to the other one (4). A unidirectional coupling between the nut member (4) and the piston rod guide (85) allows rotation in one direction by which the piston rod (6) is transported in a distal direction. The coupling has an initial reluctance to be overcome before rotation takes place said reluctance being large enough to resist torques exerted during the dose setting.
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.